Ethics assessment in research proposals adopting CRISPR technology

Area of Science:

• Biotechnology
• Bioethics
• Genomics

Background:

• The rapid advancement of genome editing technologies, including Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR), has created significant bioethical dilemmas.
• Understanding the ethical implications of these powerful tools is crucial for responsible scientific progress.

Purpose of the Study:

• To explain the nature of genome editing and the swift development of CRISPR technology.
• To outline and discuss international and European ethical assessment systems for genome editing.
• To highlight challenges in achieving a universally consistent bioethical appraisal, using cases from China as an example.

Main Methods:

• Literature review of genome editing techniques.
• Analysis of international and European bioethical frameworks.
• Case study analysis focusing on specific ethical challenges.

Main Results:

• Genome editing, particularly CRISPR, is advancing rapidly, posing complex ethical questions.
• Existing international and European systems provide frameworks for ethical assessment but face challenges.
• Discrepancies in ethical appraisal, exemplified by cases in China, hinder global consensus.

Conclusions:

• There is a pressing need for a more unified and consistent global approach to bioethical issues in genome editing.
• International collaboration is essential to navigate the ethical landscape of rapidly evolving biotechnologies.
• Addressing regional differences and specific case challenges is key to promoting universal bioethical standards.